Clinical Trials

176 enrolled

Nasopharyngeal Carcinoma

NCT03708822 2024-01-18

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

48 enrolled

Nasopharyngeal Carcinoma

NCT06032767 2024-01-05

Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep Learning

480 enrolled

Nasopharyngeal Carcinoma, Stomatitis

NCT06156878 2023-12-05

PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

41 enrolled

Nasopharyngeal Carcinoma

NCT06129201 2023-11-13

Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

5,000 enrolled

Nasopharyngeal Carcinoma

NCT03097939 2023-10-11

Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

113 enrolled

Nasopharyngeal Carcinoma

NCT05198479 2023-10-11

SG-AAA-II-01

25 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT05626829 2023-10-06

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

18 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT04593186 2023-09-07

Magnifying NBI for Occult NPC

246 enrolled

Nasopharyngeal Carcinoma

NCT05949749 2023-09-06

A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPC

1,000 enrolled

Nasopharyngeal Carcinoma

NCT05981157 2023-08-08

Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

27 enrolled

Nasopharyngeal Carcinoma

NCT02501993 2023-07-13

Nasopharyngeal Carcinoma Screening in Zhongshan City

25,000 enrolled

Nasopharyngeal Carcinoma

NCT04522050 2023-07-12

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Phase 1 Unknown

65 enrolled

Nasopharyngeal Carcinoma

NCT03925090 2023-07-03

Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients

150 enrolled

Nasopharyngeal Carcinoma

NCT03855020 2023-06-18

Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients

1,000 enrolled

Nasopharyngeal Carcinoma

NCT04072107 2023-06-18

EP-STAR

110 enrolled

Nasopharyngeal Carcinoma

NCT04221516 2023-06-18

Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma

52 enrolled

Nasopharyngeal Carcinoma

NCT03321539 2023-05-22

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

216 enrolled

Nasopharyngeal Carcinoma

NCT05771025 2023-05-19

Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases

55 enrolled

Nasopharyngeal Carcinoma

NCT04586088 2023-05-06

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

58 enrolled

Nasopharyngeal Carcinoma

NCT05531916 2023-04-14

CIPN

182 enrolled

Nasopharyngeal Carcinoma

NCT05229315 2023-04-13

PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma

45 enrolled

Nasopharyngeal Carcinoma

NCT05790200 2023-03-30

Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT05757479 2023-03-07

Steroid-Eluting Stent Implant for the Treatment of Radiation-Related Sinusitis

168 enrolled

Nasopharyngeal Carcinoma

NCT04872582 2023-02-23

Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study

33 enrolled

Nasopharyngeal Carcinoma

NCT05724355 2023-02-13

CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC

32 enrolled

Nasopharyngeal Carcinoma

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

84 enrolled

Nasopharyngeal Carcinoma

NCT04405622 2023-02-06

Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

21 enrolled

Nasopharyngeal Carcinoma

NCT03240835 2023-01-31

The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients

50 enrolled

Nasopharyngeal Carcinoma, Malnutrition

NCT04436965 2023-01-31

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

266 enrolled

Nasopharyngeal Carcinoma

NCT05682703 2023-01-12

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.

2,000 enrolled

Phase EARLY_PHASE1 Unknown

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT05654077 2022-12-19

EBV CAR-T Cells for Nasopharyngeal Carcinoma

24 enrolled

Phase EARLY_PHASE1 Unknown

Nasopharyngeal Carcinoma

NCT05616468 2022-12-15

BGT007 Cell Treatment of Nasopharyngeal Carcinoma

23 enrolled

Nasopharyngeal Carcinoma

NCT05627310 2022-11-25

Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images

50,000 enrolled

Nasopharyngeal Carcinoma

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

384 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT02063399 2022-10-17

Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

20,302 enrolled

Nasopharyngeal Carcinoma

NCT05547971 2022-09-21

Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomics

800 enrolled

Nasopharyngeal Carcinoma

NCT05448885 2022-07-08

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

50 enrolled

Nasopharyngeal Carcinoma

NCT05037357 2022-07-06

Verification of Harmonization of Plasma Epstein-Barr Virus DNA Measurements

370 enrolled

Nasopharyngeal Carcinoma

NCT05417139 2022-06-14

Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study

43 enrolled

Nasopharyngeal Carcinoma

NCT04978012 2022-06-07

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

48 enrolled

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT05201859 2022-05-06

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

150 enrolled

Nasopharyngeal Carcinoma

NCT03854838 2022-04-29

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

25 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT04143984 2022-04-29

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

146 enrolled

Nasopharyngeal Carcinoma

NCT04073784 2022-04-26

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Phase 1 Unknown

41 enrolled

Nasopharyngeal Carcinoma

NCT05341193 2022-04-22

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 1/2 Unknown

32 enrolled

Nasopharyngeal Carcinoma

NCT03346109 2022-04-06

To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma

568 enrolled

Nasopharyngeal Carcinoma

NCT04921995 2022-04-04

RETICULA-NPC

40 enrolled

Nasopharyngeal Carcinoma

NCT05299203 2022-03-28

BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Phase 1 Unknown

18 enrolled